• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经静脉导线拔除术中手术指征及心血管风险的演变

Evolution of Procedure Indication and Cardiovascular Risk in Transvenous Lead Extraction.

作者信息

Hofer Daniel, Bebié Michelle C, Kuster Noah, Steffel Jan, Breitenstein Alexander

机构信息

Division of Electrophysiology, Department of Cardiology, University Heart Center, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.

出版信息

J Clin Med. 2022 Jun 22;11(13):3596. doi: 10.3390/jcm11133596.

DOI:10.3390/jcm11133596
PMID:35806882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9267900/
Abstract

The use of cardiac implantable electronic devices (CIEDs) to treat tachy- and bradyarrhythmia has significantly increased over the past decades. Consequently, transvenous lead extractions (TLE) have been performed more frequently, particularly in the treatment of device infection or malfunction. We aimed to evaluate the development of procedure indications and cardiovascular risk factors of patients undergoing TLE over time. and methods: 277 TLE cases from 2013 to 2020 performed at the University Hospital Zurich were included in this retrospective analysis. Patient charts and follow-up letters were screened for procedure indication and cardiovascular risk factors to evaluate trends over time. 502 leads were extracted in 273 patients. The main indications for TLE remained lead dysfunction (48.7%) and infection (31.4%) throughout the investigated period; however, infections were less and device upgrade more frequently encountered indications for TLE over time. Mean patient age at the time of TLE (64.0 ± 0.9 in the entire sample) decreased over time, while the incidence of chronic kidney disease (33.6%), heart failure (48.6%), or diabetes mellitus (22%) demonstrated an increasing trend. The main indications for TLE remain device malfunction and infection, while device upgrade was increasingly encountered as an indication for TLE in recent years. Over time, patients undergoing TLE were increasingly younger and more often presented with cardiovascular risk factors.

摘要

在过去几十年中,用于治疗快速性和缓慢性心律失常的心脏植入式电子设备(CIED)的使用显著增加。因此,经静脉导线拔除术(TLE)的实施频率更高,尤其是在治疗设备感染或故障时。我们旨在评估随时间推移接受TLE的患者的手术适应症发展情况和心血管危险因素。方法:本回顾性分析纳入了2013年至2020年在苏黎世大学医院进行的277例TLE病例。对患者病历和随访信件进行筛查,以获取手术适应症和心血管危险因素,从而评估随时间的趋势。273例患者共拔除了502根导线。在整个研究期间,TLE的主要适应症仍然是导线功能障碍(48.7%)和感染(31.4%);然而,随着时间的推移,感染情况减少,而设备升级成为TLE更常见的适应症。TLE时的平均患者年龄(整个样本中为64.0±0.9)随时间下降,而慢性肾脏病(33.6%)、心力衰竭(48.6%)或糖尿病(22%)的发病率呈上升趋势。TLE的主要适应症仍然是设备故障和感染,而近年来设备升级越来越多地成为TLE的适应症。随着时间的推移,接受TLE的患者越来越年轻,并且更多地伴有心血管危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/f42049388bd4/jcm-11-03596-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/717d757f77f4/jcm-11-03596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/44c2356e2490/jcm-11-03596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/cb0d043ca2fa/jcm-11-03596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/7dddaf62baf7/jcm-11-03596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/1c93734bd934/jcm-11-03596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/b140385ca434/jcm-11-03596-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/f42049388bd4/jcm-11-03596-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/717d757f77f4/jcm-11-03596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/44c2356e2490/jcm-11-03596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/cb0d043ca2fa/jcm-11-03596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/7dddaf62baf7/jcm-11-03596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/1c93734bd934/jcm-11-03596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/b140385ca434/jcm-11-03596-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b65/9267900/f42049388bd4/jcm-11-03596-g007.jpg

相似文献

1
Evolution of Procedure Indication and Cardiovascular Risk in Transvenous Lead Extraction.经静脉导线拔除术中手术指征及心血管风险的演变
J Clin Med. 2022 Jun 22;11(13):3596. doi: 10.3390/jcm11133596.
2
Long-term mortality after transvenous lead extraction.经静脉导线拔除后的长期死亡率。
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):252-7. doi: 10.1161/CIRCEP.111.965277. Epub 2012 Feb 23.
3
Transvenous Lead Extraction during Cardiac Implantable Device Upgrade: Results from the Multicenter Swiss Lead Extraction Registry.心脏植入式设备升级过程中的经静脉导线拔除:多中心瑞士导线拔除登记研究结果
J Clin Med. 2023 Aug 8;12(16):5175. doi: 10.3390/jcm12165175.
4
Risk Factors and Long-Term Survival of Octogenarians and Nonagenarians Undergoing Transvenous Lead Extraction Procedures.八旬和九旬患者行经静脉心脏起搏器和除颤器导线拔除术的风险因素和长期生存。
Gerontology. 2021;67(1):36-48. doi: 10.1159/000511358. Epub 2020 Nov 26.
5
Safe and effective transvenous lead extraction for elderly patients utilizing non-laser and laser tools: a single-center experience in Japan.利用非激光和激光工具为老年患者进行安全有效的经静脉导线拔除:日本单中心经验。
Heart Vessels. 2021 Jun;36(6):882-889. doi: 10.1007/s00380-020-01761-3. Epub 2021 Jan 4.
6
Procedural outcome & risk prediction in young patients undergoing transvenous lead extraction-a GALLERY subgroup analysis.经静脉导线拔除术的年轻患者的手术结果及风险预测——一项GALLERY亚组分析
Front Cardiovasc Med. 2023 Sep 6;10:1251055. doi: 10.3389/fcvm.2023.1251055. eCollection 2023.
7
High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.心脏再同步治疗装置患者经静脉导线拔除术后器械相关不良事件的高复发率。
Eur J Heart Fail. 2016 Oct;18(10):1270-1277. doi: 10.1002/ejhf.558. Epub 2016 May 12.
8
Transvenous Lead Extraction of Cardiac Implantable Electronic Devices: Reimplant Strategy and Outcomes in a Single-Center Experience.心脏植入式电子设备经静脉导线拔除术:单中心经验中的再植入策略与结果
Maedica (Bucur). 2023 Sep;18(3):389-394. doi: 10.26574/maedica.2023.18.3.389.
9
Transvenous Lead Extraction (TLE) Procedure: Experience from a Tertiary Care Center in Thailand.经静脉导线拔除术(TLE):泰国一家三级医疗中心的经验。
Indian Pacing Electrophysiol J. 2022 May-Jun;22(3):123-128. doi: 10.1016/j.ipej.2022.02.021. Epub 2022 Feb 24.
10
Transvenous extraction of permanent pacemaker and defibrillator leads: Reduced procedural complexity and higher procedural success rates in patients with infective versus noninfective indications.经静脉取出永久性心脏起搏器和除颤器导线:感染性与非感染性适应证患者中,操作复杂性降低且操作成功率更高。
J Cardiovasc Electrophysiol. 2021 Feb;32(2):491-499. doi: 10.1111/jce.14841. Epub 2020 Dec 25.

引用本文的文献

1
Trends and outcomes of inpatient cardiac implantable electronic device transvenous lead extractions: a nationwide analysis.住院患者心脏植入式电子设备经静脉导线拔除的趋势与结果:一项全国性分析。
J Interv Card Electrophysiol. 2024 Aug 6. doi: 10.1007/s10840-024-01891-y.

本文引用的文献

1
Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025.全球、地区和国家 195 个国家和地区的糖尿病负担和趋势:1990 年至 2025 年的分析。
Sci Rep. 2020 Sep 8;10(1):14790. doi: 10.1038/s41598-020-71908-9.
2
Clinical outcomes of patients undergoing a cardiac implantable electronic device implantation following a recent non-device-related infection.近期非器械相关感染后行心脏植入式电子设备植入术患者的临床转归。
J Hosp Infect. 2020 Jun;105(2):272-279. doi: 10.1016/j.jhin.2020.02.003. Epub 2020 Feb 11.
3
A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver disease.
慢性肾脏病和非酒精性脂肪性肝病发病率上升的简要综述。
Physiol Int. 2019 Dec 1;106(4):305-310.
4
Kidney disease in the Global Burden of Disease Study 2017.《2017年全球疾病负担研究》中的肾脏疾病
Nat Rev Nephrol. 2019 Apr;15(4):193-194. doi: 10.1038/s41581-019-0120-0.
5
A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association.欧洲心脏病学会国家中心使用心脏植入式电子设备和介入性电生理程序的十年信息:欧洲心律协会 2017 年报告。
Europace. 2017 Aug 1;19(suppl_2):ii1-ii90. doi: 10.1093/europace/eux258.
6
Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection: Evidence From a Large US Payer Database 1-Year Post Implantation.心脏植入式电子设备感染患者的发生率、治疗强度和增量年度支出:植入后 1 年来自大型美国支付者数据库的证据。
Circ Arrhythm Electrophysiol. 2016 Aug;9(8). doi: 10.1161/CIRCEP.116.003929.
7
Cardiac Implantable Electronic Device Infection in Patients at Risk.高危患者的心脏植入式电子设备感染
Arrhythm Electrophysiol Rev. 2016 May;5(1):65-71. doi: 10.15420/aer.2015.27.2.
8
Chronic kidney disease.慢性肾脏病
Dis Mon. 2015 Sep;61(9):374-7. doi: 10.1016/j.disamonth.2015.08.001. Epub 2015 Sep 2.
9
Is the use of an additional pace/sense lead the optimal strategy for the avoidance of lead extraction in defibrillation lead failure? A single-centre experience.在除颤导联故障时,使用附加的起搏/感知导联是否是避免导联拔除的最佳策略?一项单中心经验。
Europace. 2010 Apr;12(4):522-6. doi: 10.1093/europace/eup406. Epub 2009 Dec 24.